Xavier Tizon1, Peggy Provent1,
Sebastien Parfait2, Gilles Crehange3, Johel Miteran2,
Philippe Genne1, François Brunotte2, Olivier Duchamp1,
Paul Michael Walker2
1Oncodesign, Dijon, France; 2Laboratoire
Le2i - UMR CNRS 5158, Dijon, France; 3Centre Georges-Francois
Leclerc, Dijon, France
1H-MRS
appears to be a sensitive technique to detect prostate cancer in the clinic.
The aim of this study was to establish an experimental setting to monitor the
metabolism of orthotopic prostate cancer in rats, as a candidate biomarker of
efficacy for anticancer drugs.